Demo (read-only): This page uses sample values. Nothing is uploaded, stored, or linked to an account.
Panel information (sample)
Name
Alex Demo
Sex
Male
Age
58
Fasting state
Fasted (10ā12h)
Blood draw time
08:10
Test date
Jul 29, 2025
Notes
Demo panel (sample data). Values shown here are illustrative only and not linked to any person.
This information is descriptive only. The demo does not calculate personalised interpretation and does not provide medical advice.
Panel overview
All information shown here is educational and not a substitute for medical care or personalised interpretation. FlexYourMarkers does not provide medical advice.
Clinical ranges shown here reflect standard laboratory reference intervals where available and are displayed for educational context only. Longevity context: these ranges are derived from population-level research and expert consensus about long-term resilience. They are approximate and do not represent diagnostic cut-offs, treatment goals, or medical guidance.
Panel date
Jul 29, 2025
Notes
Demo panel (sample data). Values shown here are illustrative only and not linked to any person.
Glucose & insulin
Markers related to blood sugar, insulin and long-term glucose control.
| Marker | Your value | Unit | Clinical range | Position vs clinical range | Longevity research range |
|---|---|---|---|---|---|
Glucose | 99 | mg/dL | 70 ā 99 mg/dL | Within clinical range | 80 ā 90 mg/dL |
| Short-term blood glucose regulation marker. | |||||
Insulin (fasting) | 10.4 | ĀµIU/mL | 2 ā 25 ĀµIU/mL | Within clinical range | 2 ā 6 ĀµIU/mL |
| Hormone regulating glucose uptake and metabolism. | |||||
HbA1c | 5.7 | % | 4 ā 5.6 % | Above clinical range | 4.8 ā 5.2 % |
| Average glycaemic exposure over previous months. |
Glucose
Your value99
Unitmg/dL
Clinical range70 ā 99 mg/dL
Position vs clinicalWithin clinical range
Short-term blood glucose regulation marker.
Insulin (fasting)
Your value10.4
UnitĀµIU/mL
Clinical range2 ā 25 ĀµIU/mL
Position vs clinicalWithin clinical range
Hormone regulating glucose uptake and metabolism.
HbA1c
Your value5.7
Unit%
Clinical range4 ā 5.6 %
Position vs clinicalAbove clinical range
Average glycaemic exposure over previous months.
Lipids
Cholesterol and triglyceride markers often used when discussing cardiovascular risk.
| Marker | Your value | Unit | Clinical range | Position vs clinical range | Longevity research range |
|---|---|---|---|---|---|
Total cholesterol | 236 | mg/dL | 0 ā 199 mg/dL | Above clinical range | 140 ā 180 mg/dL |
| Total circulating cholesterol across major lipoprotein fractions. | |||||
LDL-C | 156 | mg/dL | 0 ā 129 mg/dL | Above clinical range | 50 ā 80 mg/dL |
| Primary atherogenic lipoprotein fraction. | |||||
HDL-C | 52 | mg/dL | 40 ā 999 mg/dL | Within clinical range | 55 ā 85 mg/dL |
| Lipoprotein fraction often discussed in reverse cholesterol transport. | |||||
Triglycerides | 140 | mg/dL | 0 ā 149 mg/dL | Within clinical range | 50 ā 90 mg/dL |
| Energy-carrying lipids often discussed in metabolic syndrome panels. |
Total cholesterol
Your value236
Unitmg/dL
Clinical range0 ā 199 mg/dL
Position vs clinicalAbove clinical range
Total circulating cholesterol across major lipoprotein fractions.
LDL-C
Your value156
Unitmg/dL
Clinical range0 ā 129 mg/dL
Position vs clinicalAbove clinical range
Primary atherogenic lipoprotein fraction.
HDL-C
Your value52
Unitmg/dL
Clinical range40 ā 999 mg/dL
Position vs clinicalWithin clinical range
Lipoprotein fraction often discussed in reverse cholesterol transport.
Triglycerides
Your value140
Unitmg/dL
Clinical range0 ā 149 mg/dL
Position vs clinicalWithin clinical range
Energy-carrying lipids often discussed in metabolic syndrome panels.
Kidney function
Markers that are often discussed when evaluating filtration and kidney workload.
| Marker | Your value | Unit | Clinical range | Position vs clinical range | Longevity research range |
|---|---|---|---|---|---|
Creatinine Kidney marker influenced by muscle output in researchDiscussed in relation to muscle massDiscussed in relation to training load | 1.55 | mg/dL | 0.6 ā 1.3 mg/dL | Above clinical range | 0.7 ā 1.1 mg/dL |
| Muscle metabolism byproduct used to estimate kidney filtration. | |||||
Urea Discussed in relation to training load | 50 | mg/dL | 15 ā 40 mg/dL | Above clinical range | 18 ā 35 mg/dL |
| Urea is a nitrogen waste marker. Some labs report urea directly; others report BUN. These are related but not identical. |
Creatinine
Kidney marker influenced by muscle output in researchDiscussed in relation to muscle massDiscussed in relation to training load
Your value1.55
Unitmg/dL
Clinical range0.6 ā 1.3 mg/dL
Position vs clinicalAbove clinical range
Muscle metabolism byproduct used to estimate kidney filtration.
Urea
Discussed in relation to training load
Your value50
Unitmg/dL
Clinical range15 ā 40 mg/dL
Position vs clinicalAbove clinical range
Urea is a nitrogen waste marker. Some labs report urea directly; others report BUN. These are related but not identical.
Inflammation
Markers such as CRP or ESR that are discussed when looking at systemic inflammatory load.
| Marker | Your value | Unit | Clinical range | Position vs clinical range | Longevity research range |
|---|---|---|---|---|---|
CRP (high-sensitivity) Strongly influenced by inflammation in research | 3.66 | mg/L | 0 ā 5 mg/L | Within clinical range | 0.2 ā 1 mg/L |
| Low-grade systemic inflammation marker (educational only). | |||||
Homocysteine Linked to methylation pathways in research | 13.18 | Āµmol/L | 5 ā 15 Āµmol/L | Within clinical range | 5 ā 9 Āµmol/L |
| Sulphur-containing amino acid often discussed in methylation and vascular health panels (educational only). |
CRP (high-sensitivity)
Strongly influenced by inflammation in research
Your value3.66
Unitmg/L
Clinical range0 ā 5 mg/L
Position vs clinicalWithin clinical range
Low-grade systemic inflammation marker (educational only).
Homocysteine
Linked to methylation pathways in research
Your value13.18
UnitĀµmol/L
Clinical range5 ā 15 Āµmol/L
Position vs clinicalWithin clinical range
Sulphur-containing amino acid often discussed in methylation and vascular health panels (educational only).
Vitamins & micronutrients
Markers related to vitamin and micronutrient status, often discussed in the context of energy and long-term health.
| Marker | Your value | Unit | Clinical range | Position vs clinical range | Longevity research range |
|---|---|---|---|---|---|
Vitamin D (25-OH) | 57.3 | ng/mL | 20 ā 100 ng/mL | Within clinical range | 40 ā 60 ng/mL |
| 25-hydroxyvitamin D, often discussed for bone, immune and metabolic health. | |||||
Vitamin B12 | 518.9 | pg/mL | 200 ā 900 pg/mL | Within clinical range | 400 ā 800 pg/mL |
| Vitamin involved in red blood cell formation and methylation pathways. |
Vitamin D (25-OH)
Your value57.3
Unitng/mL
Clinical range20 ā 100 ng/mL
Position vs clinicalWithin clinical range
25-hydroxyvitamin D, often discussed for bone, immune and metabolic health.
Vitamin B12
Your value518.9
Unitpg/mL
Clinical range200 ā 900 pg/mL
Position vs clinicalWithin clinical range
Vitamin involved in red blood cell formation and methylation pathways.
Iron & related markers
Markers that reflect iron availability, storage and transport.
| Marker | Your value | Unit | Clinical range | Position vs clinical range | Longevity research range |
|---|---|---|---|---|---|
Ferritin Strongly influenced by inflammation in research | 664 | ng/mL | 30 ā 400 ng/mL | Well above clinical range | 50 ā 150 ng/mL |
| Iron storage protein reflecting body iron burden. |
Ferritin
Strongly influenced by inflammation in research
Your value664
Unitng/mL
Clinical range30 ā 400 ng/mL
Position vs clinicalWell above clinical range
Iron storage protein reflecting body iron burden.
Pattern notes (educational)
- Fasting glucose and HbA1c ā snapshot vs longer-term exposure. Fasting glucose provides a snapshot of blood sugar at the time of the test, whereas HbA1c reflects average glycaemic exposure over a longer period. Seeing both together highlights the difference between short-term and longer-term views of glucose exposure.How research uses this combination: This pairing appears frequently in research that compares short-term measurements with multi-month averages, helping to understand how single-time-point values relate to overall glycaemic patterns in populations.This note is educational only. It does not interpret, grade, or diagnose any individual result and is not a substitute for clinical review.
- CRP and ferritin ā acute-phase and iron storage context. CRP and ferritin can both change when the immune system is active. CRP is a classic acute-phase marker, while ferritin, best known for reflecting iron storage, can also behave as an acute-phase protein in some circumstances.How research uses this combination: Researchers sometimes evaluate CRP and ferritin together to explore how iron storage and inflammatory signalling may move in parallel or diverge across populations. FYM exposes this as an educational pattern only, with no interpretation of any individual combination.This note is educational only. It does not interpret, grade, or diagnose any individual result and is not a substitute for clinical review.
- CRP and lipids ā immune signalling and lipid transport. CRP is sometimes examined alongside lipid markers such as triglycerides, LDL, HDL or ApoB because inflammation and lipid transport can intersect in physiology. Seeing these markers together illustrates how immune-related signalling and lipid handling may be studied in combination.How research uses this combination: This combination appears in research that explores how markers of inflammatory activity and markers of lipid transport co-occur under different lifestyle or intervention scenarios. FYM presents this only as a description of how these markers are grouped in studies.This note is educational only. It does not interpret, grade, or diagnose any individual result and is not a substitute for clinical review.
Pattern notes are experimental, educational summaries based on marker combinations only. They do not use your values, do not measure risk, do not capture every relevant pattern, and are not a substitute for clinical review of your laboratory results.
Research Explorer (demo): These are external search links. They are not personalised and do not use your data.
Research explorer
This tool opens external scientific search engines using neutral, educational queries. It does not interpret results, calculate risks, or provide clinical conclusions.
Example research queries (educational)
These examples illustrate how researchers commonly phrase searches when exploring biomarker literature. They are not recommendations, interpretations, or queries specific to any individual panel.
- hs-CRP chronic low-grade inflammation human cohort studies
- LDL cholesterol ApoB cardiovascular risk epidemiology
- fasting insulin metabolic health longitudinal studies
- ferritin iron status inflammation human studies
- total testosterone metabolic health observational studies
- biomarkers ageing all-cause mortality human studies
Research findings vary by population, methodology, and context. Literature searches are intended for learning and exploration only.
Trends (educational view)
This view describes how recorded values change across recorded timestamps. It is descriptive only and does not assess health status, diagnose conditions, evaluate risk, or provide medical advice.
inflammation
| Marker | Unit | Date 1 | Date 2 | Date 3 | Date 4 | Date 5 | Date 6 | Date 7 | Date 8 | Mini chart |
|---|---|---|---|---|---|---|---|---|---|---|
CRP (high-sensitivity) 4 timepoints | mg/L | 12/01 5.3 | 28/05 3 ā | 29/07 3.66 ā | 27/09 1 ā | ā | ā | ā | ā | |
Homocysteine 4 timepoints | Āµmol/L | 12/01 20.3 | 28/05 17 ā | 29/07 13.18 ā | 27/09 11.2 ā | ā | ā | ā | ā |
CRP (high-sensitivity)
4 timepoints ā¢ mg/L
12/01
5.3
28/05
3ā
29/07
3.66ā
27/09
1ā
Homocysteine
4 timepoints ā¢ Āµmol/L
12/01
20.3
28/05
17ā
29/07
13.18ā
27/09
11.2ā
lipids
| Marker | Unit | Date 1 | Date 2 | Date 3 | Date 4 | Date 5 | Date 6 | Date 7 | Date 8 | Mini chart |
|---|---|---|---|---|---|---|---|---|---|---|
LDL-C 4 timepoints | mg/dL | 12/01 160 | 18/03 145 ā | 29/07 130 ā | 27/09 132 ā | ā | ā | ā | ā |
LDL-C
4 timepoints ā¢ mg/dL
12/01
160
18/03
145ā
29/07
130ā
27/09
132ā
iron
| Marker | Unit | Date 1 | Date 2 | Date 3 | Date 4 | Date 5 | Date 6 | Date 7 | Date 8 | Mini chart |
|---|---|---|---|---|---|---|---|---|---|---|
Ferritin 3 timepoints | ng/mL | 12/01 250 | 28/05 240 ā | 27/09 200 ā | ā | ā | ā | ā | ā |
Ferritin
3 timepoints ā¢ ng/mL
12/01
250
28/05
240ā
27/09
200ā